Aptamerlab

Aptamerlab is a private, service-oriented biotech firm providing end-to-end aptamer discovery and development solutions for clients in diagnostics and therapeutics. Its core technology involves in vitro and in vivo selection of aptamers against complex targets like whole cells and tissues, followed by rigorous characterization and structural analysis. The company has gained recognition through awards like the R-Pharm and Skolkovo startup competition and participates in international collaborative projects. Operating as a specialized CRO, its business model is likely in the early revenue stage, serving academic, pharmaceutical, and diagnostic partners.

Integrated platform for aptamer discovery including in vitro/in vivo SELEX, NGS bioinformatics, characterization (flow cytometry, microscopy), 3D structure determination via SAXS, and target identification via mass spectrometry.

Competes with other specialized aptamer CROs (e.g., Aptagen, AptaDiscovery) and the vast array of antibody service providers. Differentiation is based on its full-cycle, in-house platform, guarantee of performance, and use of complex biological targets and real clinical samples.